High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15486 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Santhosh Kuriakose und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Polymerase II, Mutation, Poly-ADP-Ribose Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, Science and Engineering Research Board.
Abstract (Originalsprache)
Objective
The Cancer Genome Atlas (TCGA) project identified favorable prognosis regarding the ultra‐mutated endometrial cancer (EC) subtype linked to polymerase epsilon gene (POLE) mutations. This study investigated POLE mutations in EC of Indian patients.
Methods
This retrospective analytical study was conducted between January 2016 and January 2023 at the Government Medical College, Kozhikode, and the MVR Cancer Center, Kozhikode, Kerala. Sanger sequencing of POLE gene exons 9 and 13 in 151 EC patients was carried out to analyze the relationship between mutations and epidemiological factors, clinicopathologic features, and treatment outcomes.
Results
Among 151 cases enrolled, 39 were unique POLE‐mutated cases. Significant associations were high‐grade tumors, myometrial invasion >50%, and Lymph‐vascular space invasion (LVSI). The median follow‐up was 40 months (95% confidence interval [CI], 34–46). A lower mean disease‐specific survival (DSS) of 51.7 months (95% CI, 43.7–59.6) was noted in the POLE‐mutated group compared with 72.11 months (95% CI, 67.60–76.62) for the POLE wild‐type. A statistically significant hazard ratio (HR) of 2.683 for DSS in the POLE‐mutated group was noted. In advanced stages (FIGO stages II–IV), a nine‐fold HR for DSS and overall survival (OS) compared with POLE wild‐type was identified. After controlling for treatment effects using Cox proportional HR, advanced‐stage POLE‐mutated tumors had a significantly higher HR of 8.67 for DSS compared with POLE‐wild‐type tumors of the same stage.
Conclusion
This study identified a unique set of POLE mutations in Indian EC patients associated with poor prognosis, which were particularly pronounced in advanced stages. Advanced stage of presentation, type of POLE mutations, and possibly ethnicity are predictors of adverse outcomes in POLE‐mutated EC. The present study highlights ethnicity as a determinant of phenotypic expression of genetic change.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India.
- Multidisciplinary Research Unit, Government Medical College, Kozhikode, Kerala, India.
- Department of Pathology, Government Medical College, Kozhikode, Kerala, India.
- Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India.
- Department of Radiation Oncology, Tertiary Cancer Care Center, Government Medical College, Kozhikode, Kerala, India.
- MVR Cancer Centre & Research Institute, Kozhikode, Kerala, India.
ORCID-Profile: Santhosh Kuriakose, Dhananjayan Dhanasooraj
Förderung
- Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India
- Science and Engineering Research Board
Zitieren
APA
Kuriakose, S., Dhanasooraj, D., Shiny, P. M., Shammy, S., Sona, V. P., Manjula, A. A., Ramachandran, A., Vijaykumar, B., Susan, N., Dinesan, M., Sankar, U. V., Ramachandran, K., & Sreedharan, P. S. (2024). High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15486
Vancouver
Kuriakose S, Dhanasooraj D, Shiny PM, Shammy S, Sona VP, Manjula AA, et al. High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15486
BibTeX
@article{Kuriakose2024,
author = {Kuriakose, Santhosh and Dhanasooraj, Dhananjayan and Shiny, P M and Shammy, S and Sona, V P and Manjula, Anupama A and Ramachandran, Amrutha and Vijaykumar, Bindu and Susan, Nayana and Dinesan, M and Sankar, Uma V and Ramachandran, Kavitha and Sreedharan, P S},
title = {High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15486}
}
EUVIMED